This Viewpoint discusses a new Centers for Medicare amp; Medicaid Services (CMS) model to expand access to novel obesity medications and lifestyle interventions for Medicare and Medicaid beneficiaries.
Gasoyan et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: